Efficiency and clinical outcomes of Moses technology for holmium laser enucleation of the prostate: An evidence‐based analysis
Authors:
- 21 September 2022
- journal article
- review article
- Published by Wiley in The Prostate
- Vol. 83 (1) , 3-15
Abstract
Background: To compare the safety and clinical efficacy of Moses laser enucleation of the prostate (MoLEP) with those of holmium laser enucleation of the prostate (HoLEP) for treating benign prostatic hyperplasia (BPH).Methods: We systematically searched PubMed, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang databases, and SinoMed databases. The retrieval period was from the establishment of the database to March 2022. Stata17.0 was used for calculations and statistical analyses.Results: This study included 12 articles comprising 1160 patients for meta‐analysis. Compared with those of the HoLEP group, the hemostasis time (weighted mean difference [WMD] = −4.66, 95% confidence interval [CI] [−6.47, −2.84], p < 0.001), enucleation time (WMD = −7.23, 95% CI [−10.67, −3.79], p < 0.001), operative time (WMD = −15.02, 95% CI [−20.50, −9.53], p< 0.001), length of hospital stay (WMD = −15.02, 95% CI [−20.50, −9.53], p< 0.001), intraoperative blood loss (WMD = −11.19, 95% CI [−12.94, −9.44], p< 0.001), and total postoperative complications rate (OR = 0.51, 95% CI [0.32, 0.81], p = 0.004) were shorter in the MoLEP group. Postoperative quality of life (WMD = 0.30, 95% CI [0.00, 0.59], p = 0.047) was lower in the HoLEP group, and there were no statistically significant differences in the International Prostate Symptom Score, postoperative maximum urinary flow rate, and postoperative residual urine (p > 0.05).Conclusion: MoLEP has more advantages than HoLEP in terms of safety, shorter operation time and hospital stay, and fewer complications. However, this conclusion needs to be verified with a larger sample size, longer follow‐up time, and multicenter randomized controlled trial data.Keywords
Funding Information
- Science and Technology Department of Sichuan Province (2020YFS0320)
This publication has 27 references indexed in Scilit:
- Thulium Laser Resection Versus Plasmakinetic Resection of Prostates in the Treatment of Benign Prostate Hyperplasia: A Meta-AnalysisJournal of Laparoendoscopic & Advanced Surgical Techniques, 2016
- Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile rangeStatistical Methods in Medical Research, 2016
- The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract SymptomsUrologic Clinics of North America, 2016
- Photoselective vaporization of the prostate with GreenLight 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis of randomized controlled trialsLasers in Medical Science, 2015
- A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An UpdateEuropean Urology, 2015
- Male Sexual Function Outcome After Three Laser Prostate Surgical Techniques: A Single Center PerspectiveUrology, 2012
- Holmium Laser Enucleation of the Prostate: A Modified Enucleation Technique and Initial ResultsJournal of Urology, 2012
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Holmium Laser Enucleation of the Prostate—Outcomes Independent of Prostate Size?Journal of Urology, 2008
- Assessing the Quality of Randomized TrialsControlled Clinical Trials, 1999